Montelukast Fexofenadine Hydrochloride Acebrophylline

Product Description

Three drugs called Levoice 3D (montelukast, acebrophylline (SR), and fexofenadine) are frequently used to treat respiratory and allergy disorders; they each focus on a distinct area of the body's inflammatory response.

Leukotriene receptor antagonists like montelukast are mostly used to treat asthma in the long run and to stop symptoms from being brought on by allergens like pollen, dust mites, and pet dander. Montelukast helps to diminish symptoms like nasal congestion and edema, lessen inflammation in the airways, and avoid asthma exacerbations by inhibiting the body's production of leukotrienes, which are inflammatory molecules.

A common bronchodilator and mucolytic for the treatment of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis is acebrophylline (SR), a pharmacological formulation with a prolonged half-life. Acebrophylline opens up the bronchial tubes by relaxing the smooth muscles lining the airways, which makes breathing easier and allows for easier airflow. It also has mucolytic properties, which aid in the thinning and breakdown of mucus in the respiratory system to facilitate its expulsion.

Second-generation antihistamine fexofenadine works by preventing the body's histamine receptors from acting, which relieves allergic reaction symptoms like runny nose, watery eyes, sneezing, and itching. Fexofenadine is less likely to sedate than first-generation antihistamines, which makes it appropriate for usage during the day without causing noticeable sleepiness.